- Report
- October 2024
- 183 Pages
Global
From €3371EUR$3,545USD£2,834GBP
€3745EUR$3,939USD£3,149GBP
- Report
- March 2025
- 50 Pages
Global
From €2520EUR$2,650USD£2,119GBP
Clofarabine is a chemotherapy drug used to treat acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). It is a purine nucleoside analog, which works by inhibiting DNA synthesis and cell division. Clofarabine is typically used in combination with other drugs, such as cytarabine, to treat AML and ALL. It is also used to treat refractory or relapsed leukemia in children and adults.
Clofarabine is approved by the US Food and Drug Administration (FDA) for the treatment of pediatric and adult patients with relapsed or refractory AML and ALL. It is also approved for use in combination with cytarabine for the treatment of pediatric patients with newly diagnosed AML.
Clofarabine is marketed by several companies, including Genzyme Corporation, Teva Pharmaceuticals, and Baxter International. It is also available as a generic drug. Show Less Read more